Aldo Di Leonardo
- Oncology top 2%
- Cancer-related Molecular Pathways 19
- Aging top 5%
- Cell Biology top 2%
- Microtubule and mitosis dynamics 18
- Molecular Biology top 5%
- DNA Repair Mechanisms 9
- RNA and protein synthesis mechanisms 9
- CRISPR and Genetic Engineering 8
- Epigenetics and DNA Methylation 6
- Advanced biosensing and bioanalysis techniques 5
- Biotechnology top 2%
-
- Genomic variations and chromosomal abnormalities 5
- Co-authors
- Geoffrey M. WahlSteven P. LinkeKristie ClarkinLaura LentiniA.-P. TsouAngela AmatoRaffaella MelfiViviana Barra
- Cited by
- OncologyAgingCell Biology
- Partner nations
- ItalyUnited StatesSpain
In The Last Decade
Aldo Di Leonardo
53 papers receiving 2.6k citations
Hit Papers
Peers
Comparison fields: 5 of 111
- Oncology 1.2k
- Aging 74
- Cell Biology 572
- Molecular Biology 1.9k
- Biotechnology 229
Countries citing papers authored by Aldo Di Leonardo
This map shows the geographic impact of Aldo Di Leonardo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aldo Di Leonardo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aldo Di Leonardo more than expected).
Fields of papers citing papers by Aldo Di Leonardo
This network shows the impact of papers produced by Aldo Di Leonardo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aldo Di Leonardo. The network helps show where Aldo Di Leonardo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Aldo Di Leonardo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2023 | 9 | |
| 3 | 2023 | 4 | |
| 4 | 2020 | 16 | |
| 5 | 2020 | 5 | |
| 6 | 2019 | 36 | |
| 7 | Caffeine boosts Ataluren's readthrough activity | 2019 | 6 |
| 8 | 2018 | 29 | |
| 9 | 2016 | 29 | |
| 10 | 2013 | 101 | |
| 11 | 2012 | 34 | |
| 12 | 2009 | 39 | |
| 13 | 2007 | 44 | |
| 14 | 2006 | 73 | |
| 15 | 2005 | 21 | |
| 16 | 2001 | 21 | |
| 17 | 1992 | 4 | |
| 18 | 1989 | 10 | |
| 19 | 1988 | 12 | |
| 20 | 1987 | 2 |
About Aldo Di Leonardo
Aldo Di Leonardo is a scholar working on Cell Biology, Oncology and Molecular Biology, having authored 54 papers that have together received 2.7k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (19 papers), Microtubule and mitosis dynamics (18 papers), DNA Repair Mechanisms (9 papers), RNA and protein synthesis mechanisms (9 papers), CRISPR and Genetic Engineering (8 papers), Epigenetics and DNA Methylation (6 papers), Genomic variations and chromosomal abnormalities (5 papers) and Advanced biosensing and bioanalysis techniques (5 papers). The work is most often cited by research in Oncology (1.2k citations), Aging (74 citations) and Cell Biology (572 citations). Aldo Di Leonardo has collaborated with scholars based in Italy, United States and Spain. Frequent co-authors include Geoffrey M. Wahl, Steven P. Linke, Kristie Clarkin, Laura Lentini, A.-P. Tsou, Angela Amato, Raffaella Melfi, Viviana Barra, Ivana Pibiri and Andrea Pace. Their work appears in journals such as Genes & Development, Oncogene and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.